Immunoreactivity for napsin A can be seen in lung adenocarcinoma [3-7], papillary thyroid carcinoma [3,4], hepatocellular carcinoma [6,7], and endometrial adenocarcinoma [3,7] as well as the renal tumor subtypes identified in this study. This evidence concerns the gene NAPSA and differentiated thyroid carcinoma.